Kiniksa Pharmaceuticals
KNSA
#4663
Rank
$1.42 B
Marketcap
🇧🇲 Bermuda
Country
$20.08
Share price
3.61%
Change (1 day)
46.68%
Change (1 year)
Categories
Operating Margin for Kiniksa Pharmaceuticals (KNSA)
Operating Margin as of May 2024 (TTM): 10.55%
According to Kiniksa Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 10.55%. At the end of 2021 the company had an Operating Margin of -406.13%.
Operating Margin history for Kiniksa Pharmaceuticals from 2022 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -406.13% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.